XML 33 R22.htm IDEA: XBRL DOCUMENT v3.25.1
Organization , Description of Business and Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Third-party Payers as a Percentage of Total
The Company’s total third-party payers and other customers in excess of 10% of total revenue and their related revenue as a percentage of total revenue were as follows:
 
 Three Months Ended March 31,
 20252024
Medicare33 %31 %
UnitedHealthcare13 %14 %
 46 %45 %

The Company's significant third-party payers in excess of 10% of total accounts receivable and their related accounts receivable balance as a percentage of total accounts receivable were as follows:
 
 March 31, 2025December 31, 2024
Medicare19 %16 %
UnitedHealthcare12 %12 %
Schedule of Revenue Revenue included in biopharmaceutical and other revenue for the three months ended March 31, 2025 and 2024 was as follows (in thousands of dollars):
 Three Months Ended March 31,
 20252024
Biopharmaceutical revenue$2,297 $953 
Contract manufacturing and testing1,287 2,051 
Total$3,584 $3,004